Scientists at the University of Nottingham have made a breakthrough in the battle to slow or prevent Parkinson's disease. They have genetically produced the first mouse model to exhibit the type of brain degeneration seen in Parkinson's and Lewy body disease, another type of dementia. The research could be used to develop targeted drugs to treat the conditions. John Mayer, who carried out the research, said: "At the moment drugs given to people with Lewy body and Parkinson's disease simply treat the symptoms. This model is the first to understand how brain cell deterioration takes place. We will use this model to identify targets for new drugs to slow or prevent the disease."
Register to continue
Why register?
- Registration is free and only takes a moment
- Once registered, you can read 3 articles a month
- Sign up for our newsletter
Subscribe
Or subscribe for unlimited access to:
- Unlimited access to news, views, insights & reviews
- Digital editions
- Digital access to THE’s university and college rankings analysis
Already registered or a current subscriber? Login